TMPRSS2:ERG–directed radiosensitization: exploiting DNA repair rewiring in gene fusion–positive prostate cancer
Journal of Clinical Investigation · 16.03.2026 · 136 (6)
DOI: 10.1172/jci203657 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.03.2026. Verfasst von Xiaoju Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Michigan Center for Translational Pathology. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Oncogene Proteins, Fusion, DNA Repair, Transcriptional Regulator ERG. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The TMPRSS2:ERG gene fusion is a truncal oncogenic event in a large subset of prostate cancers, yet its clinical relevance has remained unclear. In this issue of the JCI , Köcher et al. have demonstrated that ERG overexpression in human prostate cancer cells rewired DNA double-strand break repair toward a poly(ADP-ribose) polymerase 1–dependent (PARP1-dependent) alternative end-joining pathway without disrupting canonical repair. This repair bias created a conditional dependency on PARP1 that was exposed by radiotherapy, rendering ERG-positive tumors selectively sensitive to PARP inhibition–mediated radiosensitization. The tumor-selective cytotoxic effect of combined PARP1 inhibition and irradiation was corroborated in human-derived prostate cancer organoids. These findings establish ERG as a predictive biomarker for precision radiotherapy and highlight a tumor-selective strategy to enhance radiotherapeutic efficacy in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Michigan Center for Translational Pathology.
- Department of Pathology.
- Rogel Cancer Center.
- Howard Hughes Medical Institute, and.
- Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Wang, X., & Chinnaiyan, A. M. (2026). TMPRSS2:ERG–directed radiosensitization: exploiting DNA repair rewiring in gene fusion–positive prostate cancer. Journal of Clinical Investigation, 136(6). https://doi.org/10.1172/jci203657
Vancouver
Wang X, Chinnaiyan AM. TMPRSS2:ERG–directed radiosensitization: exploiting DNA repair rewiring in gene fusion–positive prostate cancer. Journal of Clinical Investigation. 2026;136(6). doi:10.1172/jci203657
BibTeX
@article{Wang2026,
author = {Wang, Xiaoju and Chinnaiyan, Arul M},
title = {TMPRSS2:ERG–directed radiosensitization: exploiting DNA repair rewiring in gene fusion–positive prostate cancer},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {6},
doi = {10.1172/jci203657}
}
EUVIMED